Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2017
Liquid chromatography-tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasmaSusan Christner, Jianxia Guo, Robert A Parise, et al.
Molecular Cancer Research : MCR|May 15, 2014
VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cellsJoshua D Solomon, Marjet D Heitzer, Teresa T Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
Precision Dosing of Targeted Therapies Is Ready for Prime TimeStefanie L Groenland, Remy B Verheijen, Markus Joerger, et al.
Therapeutic Drug Monitoring|January 1, 2015
An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in PlasmaJan H Beumer, Daniel Kozo, Rebecca L Harney, et al.
Pediatric Blood & Cancer|May 9, 2023
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumorsThomas Cash, Hunter C Jonus, Maya Tsvetkova, et al.
Journal of Clinical Pharmacology|April 8, 2017
Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor TypesJing Niu, Christie Scheuerell, Shailly Mehrotra, et al.
Cancer Chemotherapy and Pharmacology|September 22, 2006
Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancerJan H Beumer, Jeany M Rademaker-Lakhai, Hilde Rosing, et al.
The Journal of Extra-Corporeal Technology|May 5, 2010
In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusionHeidi Colville, Ryan Dzadony, Rebecca Kemp, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2016
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activationBrian F Kiesel, Robert A Parise, Jianxia Guo, et al.
Therapeutic Drug Monitoring|February 9, 2018
Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate CancerGuillemette E Benoist, Eric van der Meulen, Inge M van Oort, et al.
Pageof 20